269 related articles for article (PubMed ID: 15986187)
1. Chronic valproate does not alter the kinetics of docosahexaenoic acid within brain phospholipids of the unanesthetized rat.
Bazinet RP; Rao JS; Chang L; Rapoport SI; Lee HJ
Psychopharmacology (Berl); 2005 Oct; 182(1):180-5. PubMed ID: 15986187
[TBL] [Abstract][Full Text] [Related]
2. Chronic carbamazepine decreases the incorporation rate and turnover of arachidonic acid but not docosahexaenoic acid in brain phospholipids of the unanesthetized rat: relevance to bipolar disorder.
Bazinet RP; Rao JS; Chang L; Rapoport SI; Lee HJ
Biol Psychiatry; 2006 Mar; 59(5):401-7. PubMed ID: 16182257
[TBL] [Abstract][Full Text] [Related]
3. Topiramate does not alter the kinetics of arachidonic or docosahexaenoic acid in brain phospholipids of the unanesthetized rat.
Lee HJ; Ghelardoni S; Chang L; Bosetti F; Rapoport SI; Bazinet RP
Neurochem Res; 2005 May; 30(5):677-83. PubMed ID: 16176072
[TBL] [Abstract][Full Text] [Related]
4. Chronic lamotrigine does not alter the turnover of arachidonic acid within brain phospholipids of the unanesthetized rat: implications for the treatment of bipolar disorder.
Lee HJ; Rao JS; Chang L; Rapoport SI; Bazinet RP
Psychopharmacology (Berl); 2007 Sep; 193(4):467-74. PubMed ID: 17487474
[TBL] [Abstract][Full Text] [Related]
5. Chronic valproate treatment decreases the in vivo turnover of arachidonic acid in brain phospholipids: a possible common effect of mood stabilizers.
Chang MC; Contreras MA; Rosenberger TA; Rintala JJ; Bell JM; Rapoport SI
J Neurochem; 2001 May; 77(3):796-803. PubMed ID: 11331408
[TBL] [Abstract][Full Text] [Related]
6. Do lithium and anticonvulsants target the brain arachidonic acid cascade in bipolar disorder?
Rapoport SI; Bosetti F
Arch Gen Psychiatry; 2002 Jul; 59(7):592-6. PubMed ID: 12090811
[TBL] [Abstract][Full Text] [Related]
7. Valproate uncompetitively inhibits arachidonic acid acylation by rat acyl-CoA synthetase 4: relevance to valproate's efficacy against bipolar disorder.
Shimshoni JA; Basselin M; Li LO; Coleman RA; Rapoport SI; Modi HR
Biochim Biophys Acta; 2011 Mar; 1811(3):163-9. PubMed ID: 21184843
[TBL] [Abstract][Full Text] [Related]
8. Dietary n-6 polyunsaturated fatty acid deprivation increases docosahexaenoic acid metabolism in rat brain.
Igarashi M; Kim HW; Chang L; Ma K; Rapoport SI
J Neurochem; 2012 Mar; 120(6):985-97. PubMed ID: 22117540
[TBL] [Abstract][Full Text] [Related]
9. Valproic acid selectively inhibits conversion of arachidonic acid to arachidonoyl-CoA by brain microsomal long-chain fatty acyl-CoA synthetases: relevance to bipolar disorder.
Bazinet RP; Weis MT; Rapoport SI; Rosenberger TA
Psychopharmacology (Berl); 2006 Jan; 184(1):122-9. PubMed ID: 16344985
[TBL] [Abstract][Full Text] [Related]
10. Chronic olanzapine treatment decreases arachidonic acid turnover and prostaglandin E₂ concentration in rat brain.
Cheon Y; Park JY; Modi HR; Kim HW; Lee HJ; Chang L; Rao JS; Rapoport SI
J Neurochem; 2011 Oct; 119(2):364-76. PubMed ID: 21812779
[TBL] [Abstract][Full Text] [Related]
11. Valproyl-CoA and esterified valproic acid are not found in brains of rats treated with valproic acid, but the brain concentrations of CoA and acetyl-CoA are altered.
Deutsch J; Rapoport SI; Rosenberger TA
Neurochem Res; 2003 Jun; 28(6):861-6. PubMed ID: 12718439
[TBL] [Abstract][Full Text] [Related]
12. Chronic fluoxetine increases cytosolic phospholipase A(2) activity and arachidonic acid turnover in brain phospholipids of the unanesthetized rat.
Lee HJ; Rao JS; Ertley RN; Chang L; Rapoport SI; Bazinet RP
Psychopharmacology (Berl); 2007 Jan; 190(1):103-15. PubMed ID: 17093977
[TBL] [Abstract][Full Text] [Related]
13. Chronic N-methyl-D-aspartate administration increases the turnover of arachidonic acid within brain phospholipids of the unanesthetized rat.
Lee HJ; Rao JS; Chang L; Rapoport SI; Bazinet RP
J Lipid Res; 2008 Jan; 49(1):162-8. PubMed ID: 17957090
[TBL] [Abstract][Full Text] [Related]
14. Dynamics of docosahexaenoic acid metabolism in the central nervous system: lack of effect of chronic lithium treatment.
Chang MC; Bell JM; Purdon AD; Chikhale EG; Grange E
Neurochem Res; 1999 Mar; 24(3):399-406. PubMed ID: 10215514
[TBL] [Abstract][Full Text] [Related]
15. Antimanic therapies target brain arachidonic acid signaling: lessons learned about the regulation of brain fatty acid metabolism.
Lee HJ; Rao JS; Rapoport SI; Bazinet RP
Prostaglandins Leukot Essent Fatty Acids; 2007; 77(5-6):239-46. PubMed ID: 18042366
[TBL] [Abstract][Full Text] [Related]
16. Liver conversion of docosahexaenoic and arachidonic acids from their 18-carbon precursors in rats on a DHA-free but α-LNA-containing n-3 PUFA adequate diet.
Gao F; Kim HW; Igarashi M; Kiesewetter D; Chang L; Ma K; Rapoport SI
Biochim Biophys Acta; 2011; 1811(7-8):484-9. PubMed ID: 21651989
[TBL] [Abstract][Full Text] [Related]
17. Chronic nutritional deprivation of n-3 alpha-linolenic acid does not affect n-6 arachidonic acid recycling within brain phospholipids of awake rats.
Contreras MA; Chang MC; Rosenberger TA; Greiner RS; Myers CS; Salem N; Rapoport SI
J Neurochem; 2001 Dec; 79(5):1090-9. PubMed ID: 11739623
[TBL] [Abstract][Full Text] [Related]
18. Lithium and the other mood stabilizers effective in bipolar disorder target the rat brain arachidonic acid cascade.
Rapoport SI
ACS Chem Neurosci; 2014 Jun; 5(6):459-67. PubMed ID: 24786695
[TBL] [Abstract][Full Text] [Related]
19. Is the brain arachidonic acid cascade a common target of drugs used to manage bipolar disorder?
Bazinet RP
Biochem Soc Trans; 2009 Oct; 37(Pt 5):1104-9. PubMed ID: 19754461
[TBL] [Abstract][Full Text] [Related]
20. Arachidonic acid and the brain.
Rapoport SI
J Nutr; 2008 Dec; 138(12):2515-20. PubMed ID: 19022981
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
